| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.5 |